SBCH: Malt king weakening? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SBCH: Malt king weakening?

Aug 2, 2002

GlaxoSmithKline Consumer Healthcare Ltd. (erstwhile SmithKline Beecham Consumer Healthcare) posted diappointing results for the June quarter. The company posted a never before 26% decline in the topline in 1QFY03. This resulted in the margins getting squeezed and the company finally finished the quarter with a significant 45% dip in bottomline.

(Rs m) 2QFY02 2QFY03 Change 1HFY02 1HFY03 Change
Net sales 2,121 1,561 -26.4% 3,968 3,416 -13.9%
Other Income 70 39 -43.7% 153 80 -47.7%
Expenditure 1,627 1,265 -22.3% 3,092 2,660 -14.0%
Operating Profit (EBDIT) 494 296 -40.1% 875 756 -13.7%
Operating Profit Margin (%) 23.3% 19.0%   22.1% 22.1%  
Interest (net) (8) (8)   16 -5 -
Depreciation 34 34 0.0% 67 68 1.5%
Profit before Tax 538 310 -42.5% 946 773 -18.3%
Tax 135 88 -34.9% 257 257 -0.2%
Profit after Tax/(Loss) 403 222 -45.0% 688 516 -25.0%
Net profit margin (%) 19.0% 14.2%   17.4% 15.1%  
No. of Shares (eoy) (m) 45.4 45.4   45.4 45.4  
Diluted Earnings per share* 35.5 19.6   30.3 22.8  
*(annualised)            
Current P/e ratio   16.2     13.9  

The results have surprised the analyst community. Though the company has not commented on the reasons for the sharp dip in topline, it seems that the dip has more to do with an inventory correction than anything else.

Whatever the reasons, the poor results have shaken investor confidence towards the counter. GlaxoSmithKline Consumer anyway never got higher valuations owing to its one product category focus. The parent's other 100% subsidiary was always a cause for concern. But the blip in quarterly results saw the stock price lose over 13% of value ever since the results were announced.

Cost breakup
(Rs m) 2QFY02 2QFY03 Change 1HFY02 1HFY03 Change
Stock 2 (95) - (95) (115) 20.4%
RM 733 567 -22.6% 1,473 1,184 -19.6%
Finished goods 15 21 43.8% 32 32 2.2%
Staff cost 179 207 15.7% 344 400 16.1%
Advertising 152 184 21.6% 341 352 3.0%
Other exps 523 344 -34.2% 948 746 -21.3%
Patent and trademark 12 25 - 25 37 50.2%
Def. Rev. exps. 12 12 - 24 25 1.2%
Total 1,626.90 1,265 -22.3% 3,092 2,660 -14.0%

The stock is trading at Rs 317, a P/E of 14x annualised 1HFY02 earnings. We are reworking our estimation for FY03 post the surprising 2QFY03 results. Having said that, GlaxoSmithKline Consumer has traditionally had a stable business growth and there seems no reason to suggest that it may not bounce back.


Equitymaster requests your view! Post a comment on "SBCH: Malt king weakening? ". Click here!

  

More Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - COCA COLA COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS